Global Periodontal Disease Treatment Market, By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others), Treatment Type (Non-surgical Treatment, Surgical Treatment), Drugs (Systematic Antibiotics, Local Antibiotics), Route of Administration (Oral, Injectable), End-User (Hospitals, Dental Clinic, Dental Academics and Research Institutes, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) – Industry Trends and Forecast to 2030.
Periodontal Disease Treatment Market Analysis and Size
Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies. The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.
The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period. Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period. Furthermore, technological advancements in periodontal disease treatment extend profitable opportunities to the periodontal disease treatment market players in the forecast period of 2023 to 2030.
Data Bridge Market Research analyses that the Periodontal disease treatment market which was USD 734.8 million in 2022, and would rocket up to USD 61,459.3 million by 2030, and is expected to undergo a CAGR of 9.2% during the forecast period. This indicates that the market value. “Hospitals” dominates the type segment of the periodontal disease treatment market owing to the wide range of application found in hospitals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Periodontal Disease Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease and Others), Treatment Type (Non-surgical Treatment, Surgical Treatment), Drugs (Systematic Antibiotics, Local Antibiotics), Route of Administration (Oral, Injectable), End- Users (Hospitals, Dental Clinic, Dental Academics and Research Institutes and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Bausch Health Companies Inc. (Canada), Colgate-Palmolive Company (India) Limited, Mylan N.V. (U.S.), Lyne Laboratories (U.S.), WOCKHARDT (India), Xttrium Laboratories (U.S.), Sunstar Suisse S.A (Switzerland) , 3M (U.S.), Dexcel Pharma (Israel) , Izun Pharmaceuticals (U.S.), Tolmar Pharmaceuticals, Inc (U.S.), Pfizer Inc (U.S.), Noveome Biotherapeutics, Inc (U.S.), Kaken Pharmaceutical Co.,Ltd. (Japan) among others
|
|
Market Opportunities
|
|
Market Definition
Periodontal disease is defined as a progressive chronic inflammatory disease that affects the supporting as well as surrounding tissue of the gums and the underlying jawbone. This disorder can result in the serious problems such as bleeding gums, sores, tooth loss and painful chewing problems if left untreated. It is also known as gum disease or periodontitis.
Global Periodontal Disease Treatment Market Dynamics
Drivers
- Increasing prevalence of dental diseases
As per the estimates of the World Health Organization (WHO), severe periodontal disease, resulting in tooth loss is found in 15-20% of middle-aged adults (35-44 years). In addition, ageing population also poses a risk for dental disorders (such as dental cavities and periodontal disease), which results in complete tooth loss. For instance, according to WHO, about 30% of people aged 65-74 have no natural teeth.
- Rising number of geriatric population
Expanding geriatric population worldwide is predicted to favour the periodontal disease treatment demand as this population is more prone to develop diseases. The number of persons above 65 years is projected to double in the coming years. The old age people are prone to various chronic diseases such as dental disorders, which can foster the demand for the periodontal disease treatment across the globe.
According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.
The increasing geriatric population, higher volume for digital imaging and overpowering medical needs demands for the rise in periodontal disease treatment market growth. Affordability for advanced computers with PERIODONTAL DISEASE TREATMENT aided units have seen a rise over the past few years. Manufacturers of PERIODONTAL DISEASE TREATMENT equipment helps in enhancing the imaging application, the availability of small sized scanners and scanning the patients in the upright position by flat panel detector.
- Rise in inclination towards Periodontal disease treatment
Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies. Recently, higher emphasis has been placed on the dental expertise, which will further act as driver that will lead to the growth of the periodontal disease treatment market in the above mentioned projected timeframe.
Moreover, rise in inclination towards periodontal disease treatment because of the various benefits offered by it such as lower radiation dose to patients in most cases, reasonable alternative to CT in terms of cost and improved resolution, smaller acquisition times for the resolution needed in dentistry and detailed results accelerate the periodontal disease treatment market growth.
Opportunities
- Rising innovations in dentistry
Furthermore, rising innovations in dentistry are pointing towards the linkage between oral disease and medical conditions such as diabetes, heart disease, rheumatoid arthritis, and certain types of cancer. Dental and medical professionals are increasingly collaborating in order to provide optimal care, especially in the cases of medically compromised patients owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, it is observed that emerging technologies are increasingly adopted throughout dentistry. By embracing these improvements, the dental industry is increasingly becoming more patient-centric and fostering greater patient trust. Furthermore, growing convenience and consistency. This will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, high cost associated with treatment and diagnostic methods and unfavorable reimbursement scenario are the factors expected to obstruct the periodontal disease treatment market growth. Moreover, limited operating revenue opportunities for research and development of targeted therapies by various pharmaceutical industries is projected to challenge the periodontal disease treatment market in the forecast period mentioned above.
This periodontal disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the periodontal disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
Periodontal Disease Treatment Market Scope
The periodontal disease treatment market is segmented on the basis of type, treatment type, drugs, route of administration, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Gingivitis
- Chronic Periodontal Disease
- Aggressive Periodontal Disease
- Others
Treatment Type
- Non-Surgical Treatment
- Scaling And Root Planning
- Medication
- Surgical Treatment
- Flap Surgery
- Bone Grafts
- Others
Drugs
- Systematic antibiotics
- Doxycycline
- Metronidazole
- Others
- Local antibiotics
- Minocycline hydrochloride
- Chlorhexidine
Route of Administration
- Oral
- Injectable
End-User
- Hospitals
- Clinic
- Dental Clinic
- Dental Academics and Research Institutes
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Periodontal Disease Treatment Market Regional Analysis/Insights
The periodontal disease treatment market is analysed and market size insights and trends are provided by country, basis of type, treatment type, drugs, route of administration, end-user, and distribution channel as referenced above.
The countries covered in the periodontal disease treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the Periodontal disease treatment market due to the presence of major key players, growing initiatives by the local government for the improvement of oral care and provision of knowledgeable dental workforce to address the high unmet needs in this region.
Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to increasing geriatric population and growing awareness amongst consumers about the dental health.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Periodontal disease treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Periodontal disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Periodontal disease treatment market. The data is available for historic period 2015-2020.
Competitive Landscape and Periodontal Disease Treatment Market Share Analysis
The Periodontal disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the periodontal disease treatment market are:
- Bausch Health Companies Inc. (Canada)
- Colgate-Palmolive Company (India) Limited
- Mylan N.V. (U.S.)
- Lyne Laboratories (U.S.)
- WOCKHARDT (India)
- Xttrium Laboratories (U.S.)
- Sunstar Suisse S.A (Switzerland)
- 3M (U.S.)
- Dexcel Pharma (Israel)
- Izun Pharmaceuticals (U.S.)
- Tolmar Pharmaceuticals, Inc (U.S.)
- Pfizer Inc (U.S.)
- Noveome Biotherapeutics, Inc (U.S.)
- Kaken Pharmaceutical Co.,Ltd. (Japan)
SKU-